Quantcast

Prairie State Wire

Tuesday, November 5, 2024

FDA conducted second lowest number of inspections on Biologics companies in Illinois during Q3 2023

Webp r4rtnb3h764dx5zlstpe2fag0ycm

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

In the third quarter of 2023, nine Biologics companies received nine FDA inspections in Illinois, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Illinois, equalling 8.3% of all inspections in the third quarter of 2023.

Of all the Illinois companies involved in the Biologics sector, Mak-System Corporation received the most citations from the FDA in the third quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Illinois During Q3 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products71--
Compliance: Devices47--
Drug Quality Assurance13--
Food Composition, Standards, Labeling and Econ7----
Foodborne Biological Hazards51241
Human Cellular, Tissue, and Gene Therapies6----
Monitoring of Marketed Animal Drugs, Feed, and Devices42--
Postmarket Assurance: Devices91--
Vaccines and Allergenic Products7----

MORE NEWS